International Myeloma Working Group molecular classification of multiple myeloma: spotlight review-Reference-Cited by-同舟云学术

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

Published:2009-10-01 Issue:12 Volume:23 Page:2210-2221
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Fonseca R,Bergsagel P L,Drach J,Shaughnessy J,Gutierrez N,Stewart A K,Morgan G,Van Ness B,Chesi M,Minvielle S,Neri A,Barlogie B,Kuehl W M,Liebisch P,Davies F,Chen-Kiang S,Durie B G M,Carrasco R,Sezer Orhan,Reiman Tony,Pilarski Linda,Avet-Loiseau H

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2009174.pdf

Reference86 articles.

1. Kyle RA, Rajkumar SV . Multiple myeloma [see comment]. [published erratum appears in N Engl J Med 2005; 352:1163] N Engl J Med 2004; 351: 1860–1873.

2. Fonseca R . Many and multiple myeloma(s). Leukemia 2003; 17: 1943–1944.

3. Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S et al. The molecular classification of multiple myeloma. Blood 2006; 108: 2020–2028.

4. Ludwig H, Durie BG, Bolejack V, Turesson I, Kyle RA, Blade J et al. Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group. Blood 2008; 111: 4039–4047.

5. Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy J et al. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 2005; 106: 296–303.

Cited by 726 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database;Transplantation and Cellular Therapy;2024-09

2. A Representation of Metastatic Plasma Cell Myeloma as an Uncommonly Shaped Liver Tumor—A Case Report;Medicina;2024-07-30

3. Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation;JCO Precision Oncology;2024-07

4. Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real‐world setting;HemaSphere;2024-07

5. Biological Aspects of Multiple Myeloma in Pzaga Teaching Hospital Mahajanga, Western Madagascar;International Journal of Innovative Science and Research Technology (IJISRT);2024-06-20